CONAGRA BRANDS REPORTS FOURTH QUARTER AND FULL YEAR RESULTS

Conagra Brands reported FY2026 net sales of $11.28B (-2.9% YoY) and adjusted EPS of $1.72, while GAAP diluted EPS was a loss of $4.00 driven by $2.0B of goodwill and brand impairment charges. In Q4, adjusted EPS was $0.47 versus a reported diluted loss of $3.37 on the same impairments; adjusted operating margin was 11.7% (vs. 11.3% full year). For FY2027, the company guided organic net sales to -3% to -1% and adjusted EPS to $1.40-$1.50 with adjusted operating margin of 10.0%-10.5%, and it reduced its dividend to an annualized $0.70/share (from $0.35 quarterly paid in Q4).

Analysis

This is a classic packaged-food de-rating event, but the real message is not the impairment charge; it is that management is admitting the old capital-allocation model cannot support both the dividend and the margin structure. The dividend reset should mechanically remove a chunk of yield-oriented ownership, which can create another leg of selling over the next 2-6 weeks even if the stock initially stabilizes. More important, the 2027 guide implies the business is entering a lower earnings power regime, so the multiple should compress until investors see evidence that pricing and mix can offset volume erosion.

The competitive spillover is more interesting than the headline. If Conagra is forced to spend more on A&P and supply chain simplification while still guiding down volume, shelf share is likely leaking to stronger operators and private label in frozen and center-store categories. That should marginally help peers with cleaner execution and balance sheets, while suppliers tied to Conagra’s volume base face slower order growth and potentially tougher terms as the company chases simplicity.

Near term, the path of least resistance is lower on estimate cuts and passive-income selling; that is a days-to-weeks trade. Over 1-3 months, the key catalyst is whether management can show actual gross margin stabilization and working-capital discipline, because leverage near 4x limits financial flexibility. The contrarian point: the non-cash charges do clear the deck, and if the company truly cuts complexity and reinvests effectively, the stock could bottom well before earnings recover. What falsifies the bearish view is a credible FY27 bridge showing organic sales flattening and margin holding above the low end of guidance without further dividend pressure.

Key Decisions for Investors

• Short CAG into any post-earnings bounce; use a 2-6 week horizon and cover if the stock reclaims the pre-announcement gap or management signals no further guidance risk on the next call.
• Pair trade: short CAG / long XLP or PBJ to isolate company-specific execution risk while hedging broad staples beta; best entry is after the first reflex rally fades.
• For a more idiosyncratic relative-value expression, short CAG vs. long GIS only if GIS shows stable volume and no incremental margin reset; otherwise keep the hedge broad with XLP.
• Avoid chasing the dividend-cut relief trade for now; wait for one quarterly read on FCF and margin before considering a long, because the first-order catalyst is still estimate compression.
• Alert level: if FY27 organic sales move to flat-to-up and adjusted operating margin holds above 10.5%, reassess the short, since that would indicate the turnaround is gaining traction faster than expected.